Determination of Epidemiological Markers and Seroprevalence of Chlamydia Trachomatis in Female Sti Attendees

The present study was attempt to determine the seroprevalence of chlamydia trachomatis and its association with various epidemiological markers. Sexually transmitted infections are most commonly caused by Chlamydia trachomatis (STIs). Undiagnosed and untreated chlamydial infections might have permanent consequences. Patients who are infected act as a source of infection for their partners. The goal of this study was to find out what epidemiological signs and seroprevalence of genital Chlamydia there were in female STI patients who went to STI clinics. The seroprevalence of chlamydia trachomatis, as well as age, marital status, history of sexual contact, and contraceptive use, were evaluated in 226 clinically suspected cases of Sexually Transmitted Infection (STI) patients attending a STI clinic. Using an ELISA(Novatech, Germany) test, patients were checked for the presence of chlamydia trachomatis IgG antibody . By ELISA, chlamydia trachomatis seroprevalence was revealed to be 55.66 percent for IgG. Sexually active people were more likely to have genital Chlamydia (21-30 years). Patients who were married (53.75 percent), had a history of sexual interaction (61.25 percent), and were taking oral contraceptive pills as a contraceptive strategy (63.93 percent) had the highest prevalence. Although tissue culture is the gold standard for detecting chlamydia trachomatis, serological assays are significantly more straightforward, sensitive, and quick. The need of early laboratory diagnosis and appropriate therapy for Chlamydia and other STIs is highlighted by the co-infection of Chlamydia with other STIs.